Ignite Creation Date:
2025-12-26 @ 4:02 PM
Ignite Modification Date:
2026-02-24 @ 8:48 AM
Study NCT ID:
NCT02963506
Status:
COMPLETED
Last Update Posted:
2023-06-06
First Post:
2016-11-10
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Evaluate the Efficacy and Safety of Different Doses of Bimekizumab in Subjects With Active Ankylosing Spondylitis
Sponsor:
UCB Biopharma S.P.R.L.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-10
Start Date Type:
ACTUAL
Primary Completion Date:
2017-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-08
Completion Date Type:
ACTUAL
First Submit Date:
2016-11-10
First Submit QC Date:
None
Study First Post Date:
2016-11-15
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2020-10-21
Results First Submit QC Date:
None
Results First Post Date:
2020-11-16
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2018-10-23
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2023-05-09
Last Update Post Date:
2023-06-06
Last Update Post Date Type:
ACTUAL